The Lions World Vision Institute (LWVI) employs a range of advanced technologies and methodologies to enhance sight restoration and ocular health. Central to their mission is the innovative use of tissue processing techniques, such as the hydrodissection method for Descemet Membrane Endothelial Keratoplasty (DMEK), which minimizes trauma to the graft and improves surgical outcomes. Their research and clinical development initiatives focus on optimizing corneal transplant procedures, including the use of preloaded grafts in EndoGlide systems, which streamline surgical processes and reduce operating times. Additionally, LWVI's OptiGraft program expands the utility of donated tissues, allowing for the sterilization and repurposing of corneal and scleral tissues to benefit multiple patients, thereby maximizing the impact of each donation.

Furthermore, LWVI is committed to advancing ocular research through its Ocular Research Center, which provides state-of-the-art facilities for tissue handling, grading, and preparation. The center supports a variety of research activities, including genotyping and phenotyping of ocular tissues, as well as contract research organization (CRO) services that assist researchers in all stages of the preclinical pipeline. Their comprehensive histology and imaging capabilities enable meticulous analysis of ocular samples, while their extensive biobank offers validated human primary cell lines and ocular tissues for research purposes. Through these technologies and resources, LWVI aims to foster innovation in sight restoration and contribute significantly to the global understanding of ocular health.

United States

Lions Eye Institute for Transplant & Research (LEITR) is one of the largest eye banks in the world. The organization facilitates vision services and transplantation.

Lions World Vision Institute

Company Details